Virtus Family Office LLC Makes New $814,000 Investment in The Clorox Company $CLX

Virtus Family Office LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,073 shares of the company’s stock, valued at approximately $814,000.

Other large investors have also recently made changes to their positions in the company. Vanguard Personalized Indexing Management LLC raised its stake in shares of Clorox by 64.2% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock worth $3,173,000 after acquiring an additional 10,065 shares in the last quarter. Wilkins Investment Counsel Inc. raised its stake in shares of Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Clorox by 11.7% during the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after acquiring an additional 136,135 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Clorox by 27.0% during the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after acquiring an additional 197,330 shares in the last quarter. Finally, Eliot Finkel Investment Counsel LLC purchased a new position in shares of Clorox during the third quarter worth approximately $1,697,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CLX has been the topic of several research reports. Morgan Stanley decreased their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Rothschild & Co Redburn set a $117.00 target price on shares of Clorox in a research note on Friday, February 13th. Evercore reaffirmed an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday, May 1st. Finally, The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $104.00.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.63% of the stock is currently owned by company insiders.

Clorox Stock Up 2.4%

Shares of NYSE CLX opened at $92.20 on Friday. The company has a market cap of $11.15 billion, a price-to-earnings ratio of 14.97, a PEG ratio of 0.47 and a beta of 0.59. The firm’s fifty day moving average is $106.03 and its 200 day moving average is $108.04. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $138.94. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts expect that The Clorox Company will post 5.63 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be issued a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.4%. Clorox’s payout ratio is 80.52%.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.